Misonidazole combined with hyperfractionation in the management of malignant glioma
- 1 September 1984
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 10 (9), 1709-1712
- https://doi.org/10.1016/0360-3016(84)90533-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group studyCancer, 1983
- A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG studyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Accelerated fractionation vs hyperfractionation: Rationales for several treatments per dayInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trialCancer, 1982
- Super fractionation in glioblastoma multiforme-results of a phase II studyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trialBritish Journal of Cancer, 1982
- Superfractionation: its rationale and anticipated benefitsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationshipsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Assumptions in the radiotherapy of glioblastomaNeurology, 1980
- An analysis of dose-effect relationship in the radiotherapy of malignant gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1979